Correction to: Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes.

Christophe PisonPallav L ShahDirk-Jan SlebosVincent NinaneWim JanssensThierry PerezRomain KesslerGaetan DesleeJustin L GarnerJorine E HartmanBruno DeganoAnna MayrMartin MayseAlexander D PetersonArschang Valipour

Published in: Respiratory research (2021)

Keyphrases

chronic obstructive pulmonary disease
lung function
cancer therapy
type diabetes
skeletal muscle
insulin resistance
glycemic control